We are live on
!
Find out more
Nomura Holdings Portfolio holdings
AUM
$37.7B
1-Year Est. Return
34.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.61%
1 Year Est. Return
+34.44%
3 Year Est. Return
+90.26%
5 Year Est. Return
+115.49%
10 Year Est. Return
+595.58%
AUM
$43.6B
AUM Growth
-$8.59B
(-16%)
Cap. Flow
-$10.4B
Cap. Flow
% of AUM
-23.95%
Top 10 Holdings %
Top 10 Hldgs %
42.61%
Holding
2,109
New
373
Increased
412
Reduced
521
Closed
614
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$879M |
| 2 |
Meta Platforms (Facebook)
META
|
+$252M |
| 3 |
Marathon Petroleum
MPC
|
+$218M |
| 4 |
Coinbase
COIN
|
+$152M |
| 5 |
Crown Castle
CCI
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$910M |
| 2 |
Texas Instruments
TXN
|
+$775M |
| 3 |
Dollar Tree
DLTR
|
+$615M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$581M |
| 5 |
NVIDIA
NVDA
|
+$489M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.08% |
| 2 | Consumer Discretionary | 5.26% |
| 3 | Communication Services | 2% |
| 4 | Healthcare | 1.8% |
| 5 | Energy | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
PUT
Oracle
ORCL
$422B
| $324K | ﹤0.01% |
+1,900
| New | +$275K |
|
|
VERV
1227
DELISTED
Verve Therapeutics
VERV
| $314K | ﹤0.01% |
64,773
-10
| -0% | -$58 |
|
1228
CALL
Sarepta Therapeutics
SRPT
$1.76B
| $312K | ﹤0.01% |
2,500
-27,700
| -92% | -$3.83M |
|
1229
Helen of Troy
HELE
$686M
| $308K | ﹤0.01% |
+4,979
| New | +$294K |
|
1230
Franklin Resources
BEN
$17.1B
| $308K | ﹤0.01% |
15,262
-4,155
| -21% | -$89.5K |
|
1231
Select Water Solutions
WTTR
$2.88B
| $307K | ﹤0.01% |
27,541
-15,262
| -36% | -$168K |
|
1232
Vaxcyte
PCVX
$8.49B
| $306K | ﹤0.01% |
+2,681
| New | +$242K |
|
1233
TPG
TPG
$7.88B
| $305K | ﹤0.01% |
+5,303
| New | +$261K |
|
1234
Tandem Diabetes Care
TNDM
$1.47B
| $303K | ﹤0.01% |
7,151
-1,963
| -22% | -$83.2K |
|
1235
Criteo S.A. Ordinary Shares
CRTO
$925M
| $302K | ﹤0.01% |
+7,500
| New | +$330K |
|
1236
PUT
Dow Inc
DOW
$21.5B
| $300K | ﹤0.01% |
5,500
| – | – |
|
1237
Celsius Holdings
CELH
$6.76B
| $298K | ﹤0.01% |
+9,502
| New | +$399K |
|
|
NVO
1238
CALL
Novo Nordisk
NVO
$208B
| $298K | ﹤0.01% |
+2,500
| New | +$333K |
|
|
BCYC
1239
Bicycle Therapeutics
BCYC
$291M
| $296K | ﹤0.01% |
+13,095
| New | +$302K |
|
1240
Madrigal Pharmaceuticals
MDGL
$11.9B
| $296K | ﹤0.01% |
+1,394
| New | +$357K |
|
1241
Vipshop
VIPS
$7.52B
| $293K | ﹤0.01% |
18,614
-107,271
| -85% | -$1.44M |
|
1242
CALL
Super Micro Computer
SMCI
$19.9B
| $291K | ﹤0.01% |
7,000
| – | – |
|
|
ZH
1243
Zhihu
ZH
$279M
| $289K | ﹤0.01% |
+75,000
| New | +$242K |
|
1244
PUT
Viking Therapeutics
VKTX
$3.91B
| $285K | ﹤0.01% |
+4,500
| New | +$264K |
|
1245
Canadian Pacific Kansas City
CP
$80.3B
| $282K | ﹤0.01% |
3,300
+400
| +14% | +$32.9K |
|
1246
Jazz Pharmaceuticals
JAZZ
$16.7B
| $281K | ﹤0.01% |
+2,520
| New | +$276K |
|
1247
PUT
MetLife
MET
$62.2B
| $280K | ﹤0.01% |
+3,400
| New | +$254K |
|
1248
Kimberly-Clark
KMB
$36.2B
| $271K | ﹤0.01% |
1,908
-2,962
| -61% | -$420K |
|
1249
Invesco Mortgage Capital
IVR
$812M
| $271K | ﹤0.01% |
+28,866
| New | +$259K |
|
1250
Cimpress
CMPR
$2.31B
| $270K | ﹤0.01% |
+3,299
| New | +$292K |
|
Similar funds
Nomura Holdings's Q3 2024 Portfolio in Review
As of Q3 2024, Nomura Holdings held 2,109 positions worth $43.6B, down 16% from $52.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Nomura Holdings withdrew a net $10.4B in Q3 2024, closing 614 positions and reducing 521 holdings. Its most notable exit was Aptiv, an estimated $98.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Nomura Holdings opened a new position in Henry Schein worth $74.6M.
- Nomura Holdings's largest Q3 2024 buy was Henry Schein: 1,023,769 shares worth $74.6M.
- Nomura Holdings added most to Tesla in Q3 2024, an estimated $879M increase.
- Nomura Holdings's biggest Q3 2024 reduction was Cognizant, cutting an estimated $910M.
- Nomura Holdings fully exited Aptiv in Q3 2024, selling an estimated $98.6M.
- Nomura Holdings's ten largest holdings make up 43% of its $43.6B portfolio in Q3 2024.
- Nomura Holdings opened 373 new positions and closed 614 in Q3 2024.
- Nomura Holdings's portfolio value fell 16% quarter-over-quarter to $43.6B.
Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.